Bioequivalence Between 180 mg and 60 mg ALXN2050 Tablets and Food Effect on ALXN2050 Pharmacokinetics
Clinical trial NCT05578846 · COMPLETED
Trial details
- NCT number
- NCT05578846
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-13
- Primary completion
- 2023-01-05
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.